|
NKTR Nektar Therapeutics 906709 |
| Balance Sheet |
|
Current Assets
|
$589,041,000.00 |
|
Assets
|
$763,271,000.00 |
|
Current Liabilities
|
$57,708,000.00 |
|
Liabilities
|
$187,055,000.00 |
|
Equity
|
$576,216,000.00 |
|
Shares Out
|
20378832.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-44,298,000.00 |
|
Investing Cash Flow
|
$-350,789,000.00 |
| Market Analysis |
Market Cap
|
$1,456,067,546.40 |
|
Price
|
$67.95 |
|
BVPS
|
28.28 |
|
PB
|
2.53 |
|
EPS
|
-1.82 |
|
PS
|
33.32 |
|
FCF
|
$-44,316,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:22 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:18 |
|
| Apr |
May |
Jun |
| 2026-03-12 |
-1.78 |
|
|
2026-05-07 |
-1.82 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-07 |
-2.95 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-06 |
-1.87 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view NKTR documents filed with the SEC.
NKTR Filings
Clear
